ArticleInternational journal of general medicine2026
Predictive Value of S100A8/A9 Combined with sSDC1 in Vaginal Lavage Fluid for Persistent High-Risk HPV Infection and Vaginal Dysbiosis.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the association of vaginal lavage fluid levels of S100 calcium-binding protein A8/A9 complex (S100A8/A9) and soluble syndecan-1 (sSDC1) with high-risk human papillomavirus (HR-HPV) persistent infection and vaginal microecology. Methods: In this prospective cohort study, 403 HR-HPV--positive patients without cervical intraepithelial neoplasia grade 2 or worse were enrolled between April 2023 and February 2024. Genotypes included HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68, 12 of which are Group 1 carcinogens per the International Agency for Research on Cancer (IARC). Over 2 years, 245 cleared and 158 had persistent infection. Enzyme-linked immunosorbent assay measured S100A8/A9 and sSDC1 levels. Spearman correlation assessed relationships with viral load and vaginal pH. LASSO regression screened variables, followed by multivariable logistic regression. Receiver operating characteristic (ROC) curves evaluated predictive performance. Results: In the persistent infection group, HPV16 (39.87%) and HPV18 (22.78%) predominated. S100A8/A9, sSDC1, and dysbiosis indicators were higher in the persistent group (all Conclusion: Elevated vaginal S100A8/A9 and sSDC1 are independent risk factors for persistent HR-HPV infection and vaginal dysbiosis. Combined testing (AUC=0.870) may aid risk stratification. This single-center exploratory study lacked HPV-negative controls and external validation, requiring multicenter confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.